TheKicksShrink
TheKicksShrink
Minisode 74 - Vyvanse Shortage 2024...Here We Go Again :|
Minisode 74 - Vyvanse Shortage 2024...Here We Go Again :|
Minisode 74 - Vyvanse Shortage 2024...Here We Go Again :|
Saturday 27th April 2024
Discover the complexities of the 2024 Vyvanse shortage and explore alternative medication options and non-pharmaceutical strategies to manage ADHD effectively. Join Dr. Salman Aziz Mirza on TheKicksShrink Podcast.
Explicit
11 minutes
Inspiring
Empowering
Informative
Supportive
Encouraging
About this podcast
Author:
TheKicksShrink
Overview:
Categories:
Sobriety Toolkit
Innovative Treatments & Recovery Paths
Recovery from Trauma
Mindfulness & Technology in Health
Sexual Stigmas & Myths
Links:
Visit site
Episodes:
107 (View all)
Do you want to link to this podcast?
Get the buttons here!Navigating the 2024 Vyvanse Shortage: Insights and Strategies
Episode Overview
- Exploration of 2024 Vyvanse shortage complexities and impact on patients
- Insights into alternative ADHD medication options like Adderall XR, Azstarys, and Mydayis
- Discussion on non-pharmaceutical strategies for managing ADHD effectively amidst the shortage
- Consideration of DEA regulations and their role in the medication supply chain
- Encouragement of community support and resilience in facing ADHD challenges
You're not alone in this. Lean on each other. Share your struggles and your triumphs. You've got the strength and the smarts to knock them out of the park.
In the latest episode of TheKicksShrink Podcast, Dr. Salman Aziz Mirza, aka TheKicksShrink, dives into the 2024 Vyvanse shortage, shedding light on the complexities causing millions of ADHD patients distress. Dr. Mirza discusses the factors contributing to the shortage, including production hurdles, DEA regulations, and the impact on individuals' daily lives. Offering insights into alternative medications like Adderall XR, Azstarys, and Mydayis, he explores non-pharmaceutical strategies to navigate ADHD successfully amidst the shortage.